Concepedia

Hans van Tol

HV

Statistics

Publications

15

Citations

1.9K

H-Index

15

Active since

1986

Affiliations

Leiden University Medical Center(Current)

University of Würzburg

Utrecht University

University of California, Davis

Meertens Institute

Hans van Tol is an author at Leiden University Medical Center specializing in life sciences, molecular biology, and virology.

Publications per year

1986–2005

15

Publications

15

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

Herman Burger, Hans van Tol, Antonius W.M. Boersma et al. · Blood · 2004 · 415 citations · Full text

, , +11

Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps

Herman Burger, Hans van Tol, Mariël Brok et al. · Cancer Biology & Therapy · 2005 · 204 citations · Full text

, , +15

Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex

Eric J. Snijder, Hans van Tol, Norbert Roos et al. · Journal of General Virology · 2001 · 200 citations

, , +17

Identification of a Novel Structural Protein of Arteriviruses

Eric J. Snijder, Hans van Tol, Ketil Winther Pedersen et al. · Journal of Virology · 1999 · 181 citations · Full text

, , +17

Two autolytic processing reactions of a satellite RNA proceed with inversion of configuration

Hans van Tol, Jamal M. Buzayan, Paul A. Feldstein et al. · Nucleic Acids Research · 1990 · 171 citations · Full text

, , +16

1–5 of 15